These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1282464)

  • 1. Autonomic effects of antiarrhythmic drugs and their importance.
    Lombardi F; Torzillo D; Sandrone G; Dalla Vecchia L; Cappiello E
    Eur Heart J; 1992 Nov; 13 Suppl F():38-43. PubMed ID: 1282464
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system.
    Stramba-Badiale M; Lazzarotti M; Facchini M; Schwartz PJ
    Am Heart J; 1994 Nov; 128(5):973-82. PubMed ID: 7524295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW; Nayebagha A; Fabry E
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The characteristics of the autonomic regulation of the heart rate in patients with IHD and ventricular arrhythmias under obzidan therapy].
    Belogubets VI; Polevaia TIu; Afonskaia NI; Smetnev AS
    Ter Arkh; 1994; 66(8):32-4. PubMed ID: 7527162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tachycardias: considerations in childhood in the 90s].
    Gutiérrez-Larraya F; Jabón A
    An Esp Pediatr; 1993 Dec; 39(6):475-88. PubMed ID: 8166400
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-blocking effect of propafenone based on spectral analysis of heart rate variability.
    Lombardi F; Torzillo D; Sandrone G; Dalla Vecchia L; Finocchiaro ML; Bernasconi R; Cappiello E
    Am J Cardiol; 1992 Oct; 70(11):1028-34. PubMed ID: 1357951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy.
    Takanaka C; Nonokawa M; Machii T; Lee S; Kato H; Haruna M; Yabe S
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2130-3. PubMed ID: 1279613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with mexiletine. Clinical and pharmacokinetic studies].
    Breithaupt H; Schmidt A
    Klin Wochenschr; 1988 Jun; 66(11):475-81. PubMed ID: 2457131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
    Capucci A; Di Pasquale G; Boriani G; Carini G; Balducelli M; Frabetti L; Carozzi A; Finzi A; Pinelli G; Magnani B
    Int J Clin Pharmacol Res; 1991; 11(1):23-33. PubMed ID: 1714885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of flecainide and mexiletine for the treatment of ventricular tachyarrhythmias.
    Jordaens LJ; Tavernier R; Vanmeerhaeghe X; Robbens E; Clement DL
    Pacing Clin Electrophysiol; 1990 Sep; 13(9):1127-35. PubMed ID: 1700388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical use of class IC antiarrhythmic drugs.
    Abi Samra F
    J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term inotropic effects of flecainide and propafenone.
    Henze E; Roth J; Haerer W; Adam WE; Stauch M
    Eur J Nucl Med; 1988; 13(11):568-71. PubMed ID: 2450751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
    Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular tachyarrhythmias in a canine model of LQT3: arrhythmogenic effects of sympathetic activity and therapeutic effects of mexiletine.
    Chinushi M; Tagawa M; Sugiura H; Komura S; Hosaka Y; Washizuka T; Aizawa Y
    Circ J; 2003 Mar; 67(3):263-8. PubMed ID: 12604879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis, recognition, and management of common cardiac arrhythmias. Part I: Ventricular premature beats and tachyarrhythmias.
    Alpert MA; Mukerji V; Bikkina M; Concannon MD; Hashimi MW
    South Med J; 1995 Jan; 88(1):1-21. PubMed ID: 7529434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
    Mastropasqua F; Totaro P; Massari F; Pitzalis MV; Rizzon P
    Cardiologia; 1998 Jun; 43(6):617-23. PubMed ID: 9675961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of diurnal variation of ventricular repolarization to ventricular ectopic activity and modification by sotalol.
    Hohnloser SH; Zabel M; Just H; Raeder EA
    Am J Cardiol; 1993 Feb; 71(5):475-8. PubMed ID: 7679244
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.
    Yeung-Lai-Wah JA; Murdock CJ; Boone J; Kerr CR
    J Am Coll Cardiol; 1992 Sep; 20(3):547-51. PubMed ID: 1512331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.